Candesartan Tablet
Product Images NDC 71335-3032

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Candesartan (NDC 71335-3032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Candesartan Figure1s)

A hazard ratio forest plot chart displaying subgroup analyses for Candesartan cililexetil compared to placebo. The plot compares age, sex, race, NYHA class, LVEF, medical history, and various medication uses across patient groups. Each subgroup is represented with points and confidence intervals indicating whether Candesartan or placebo is favored, with a vertical line at 1.0 indicating neutrality.*

FDA Label Image

1 (Candesartan Structure1s)

Chemical structure diagram of Candesartan, showing the molecular components and indicating the site of ester hydrolysis with an arrow.*

FDA Label Image

Label (Lbl713353032)

Label for Candesartan Cilexetil Tablets, USP 16 mg, repackaged by Bryant Ranch Prepack, Inc. The label states a quantity of 30 tablets, includes storage instructions at controlled room temperature, and notes the manufacturer as Macleods Pharmaceuticals Ltd. The label features two QR codes and a barcode, with the NDC 71335-3032-1 prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.